BENEFITS OF PROPHYLACTIC USE OF PERSONALIZED INSOLES FOR PATIENTS TREATED WITH REGORAFENIB

被引：0
|
作者：
Tsuji, Yasushi [1 ]
Kitayama, Hiromitsu [1 ]
Sugiyama, Junko [1 ]
Sugimoto, Hisashi [2 ]
Takasaki, Syuichi [3 ]
Mitsuno, Kaoru [4 ]
Hirayama, Masaaki [5 ]
机构：
[1] Tonan Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan
[2] Tonan Hosp, Dept Rehabil Serv, Sapporo, Hokkaido, Japan
[3] Tonan Hosp, Dept Pharmacol, Sapporo, Hokkaido, Japan
[4] Tonan Hosp, Nursing Off, Sapporo, Hokkaido, Japan
[5] Tonan Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu396.1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SS-2
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The effect of gastrectomy in regorafenib treated GIST patients on outcome and drug exposure.
    Van Erp, Nielka P.
    Lubberman, Floor
    Van der Graaf, Winette T. A.
    Xu, Lei
    Cleton, Adriaan
    Gelderblom, Hans
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [32] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Schirripa, M.
    Loupakis, F.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    Antoniotti, C.
    D'Aurzio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Aquila, E. Dell'
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [33] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Antoniotti, C.
    Loupakis, F.
    Schirripa, M.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    D'Aurizio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Dell'Aquila, E.
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 38
  • [34] The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice
    Yoon, Sang Eun
    Lee, Su Jin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    Kim, Seung Tae
    ONCOTARGETS AND THERAPY, 2019, 12 : 225 - 231
  • [35] Potential Benefits of Prophylactic Cholecystectomy in Patients Undergoing Bariatric Bypass Surgery
    A. Hussain
    S. EL-Hasani
    Obesity Surgery, 2016, 26 : 865 - 865
  • [36] Potential Benefits of Prophylactic Cholecystectomy in Patients Undergoing Bariatric Bypass Surgery
    Hussain, A.
    El-Hasani, S.
    OBESITY SURGERY, 2016, 26 (04) : 865 - 865
  • [37] Potential Benefits of Prophylactic Cholecystectomy in Patients Undergoing Bariatric Bypass Surgery
    Sébastien Amstutz
    Jean-Marie Michel
    Sébastien Kopp
    Bernhard Egger
    Obesity Surgery, 2015, 25 : 2054 - 2060
  • [38] Potential Benefits of Prophylactic Cholecystectomy in Patients Undergoing Bariatric Bypass Surgery
    Amstutz, Sebastien
    Michel, Jean-Marie
    Kopp, Sebastien
    Egger, Bernhard
    OBESITY SURGERY, 2015, 25 (11) : 2054 - 2060
  • [39] PROPHYLACTIC USE OF ANTIBIOTICS IN SURGICAL PATIENTS IN BELGIUM
    ALPEROVITCH, A
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 1988, 36 (01): : 77 - 78
  • [40] Regorafenib: A Review of Its Use in Patients with Advanced Gastrointestinal Stromal Tumours
    Shirley, Matt
    Keating, Gillian M.
    DRUGS, 2015, 75 (09) : 1009 - 1017
12345